Evidence map›Paper›PMID 42067525›Full record

ArticleScientific reports2026

Integrating Artificial intelligence within sustainable smart analytical chemistry for analyzing the divisor impact on UV-spectrophotometric efficiency of solifenacin and mirabegron combination.

Hayam M Lotfy, Reem H Obaydo, Mahmoud A Tantawy, Aya A Mouhamed

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hayam M LotfyPharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, El-Kasr El-Aini Street, Cairo, 11562, Egypt.
Reem H ObaydoDepartment of Analytical and Food Chemistry, Faculty of Pharmacy, Ebla Private University, 22743, Idlib, Syria.
Mahmoud A TantawyDepartment of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah, 51452, Saudi Arabia.
Aya A MouhamedPharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, El-Kasr El-Aini Street, Cairo, 11562, Egypt. aya.ahmed@pharma.cu.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study examines the influence of divisor selection on the efficacy of advanced analytical spectrophotometric methods that integrate artificial intelligence (AI), green-chemistry principles, and white-analytical-chemistry (WAC) frameworks for pharmaceutical investigation. Advanced analytical chemistry, which combines environmental sustainability, analytical practice and computational cleverness, was employed to create innovative spectrophotometric techniques for the concurrent quantification of solifenacin succinate (SOF), and mirabegron (MIR), both utilized in the treatment of overactive bladder. Three divisor approaches were evaluated within complementary smart resolution strategies based on high impact amplitude manipulation method (HIAM) using normalized divisor of MIR, concentration-dependent divisor of MIR at 3.0, 8.0, and 14.0 µg/mL, as well as extracted zero order spectra of MIR obtained by absorbance resolution method (AR). Linearity for SOF was observed from 2.5 to 25.0 µg/mL using first derivative D

Indexed as

AcetanilidesArtificial IntelligenceSolifenacin SuccinateThiazolesAniline CompoundsSpectrophotometry, UltravioletAcetanilidesAniline CompoundsmirabegronSolifenacin SuccinateThiazolesConcentration dependent divisorExtracted divisor mirabegronNormalized divisor (ND)Smart Analytical chemistrySolifenacin succinateSustainable Smart Analytical Chemistry

Identifiers

PMID42067525
PMCPMC13134955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.